|
||
|
Venture capital firms and funds in Europe 128 Venture Capital Group 3i Venture Capital Accuitive Medical Acer Venture Capital Act Venture Capital Ltd Adelaide Venture Capital Email ADS Ventures Boston Advantages Of Venture Capital Advent Venture Capital Agio Capital Alabama Venture Capital Alaska Venture Capital All Stages Venture Capital American Venture Capital Analysis Venture Capital Analyze Venture Capital Angel Capital Appraisal Venture Capital Arch Venture Capital Argentina Venture Capital Arizona Venture Capital Arkansas Venture Capital Arrowpath Venture Capital Assess Venture Capital Assessment Venture Capital Atlas Venture Capital ATV Venture Capital Aurora Fund Australia Venture Capital Austria Venture Capital Automotive Venture Capital AZ Venture Capital VCgate More Venture Capital Terms and Topics
-
Proteus Biomedical Raises $32 Million in Series D Funding
October 15th, 2008 No comments
Proceeds to Advance Development of Intelligent Medicine Products
REDWOOD CITY, Calif. Proteus Biomedical Inc., a pioneer in intelligent medicine, announced today that the company has raised $32 million in a series D equity financing. New corporate investors Medtronic and Itochu join existing investors St. Jude Medical, Adams Street Partners, The Carlyle Group, Essex Woodlands, Kaiser Permanente Ventures, Spring Ridge Ventures and others. The company’s current round of financing will remain open for a period of time to additional investors.
Proteus develops products that integrate its proprietary in-body electronics and sensor technologies into existing medical devices and pharmaceuticals to dramatically improve therapeutic outcomes. This round funds the company’s cardiovascular therapeutic device programs through development and manufacturing, and advances its cardiovascular and other pharmaceutical systems programs through multiple human studies.
“I am pleased that we have attracted world-leading investors who endorse our vision of intelligent medicine and recognize the company’s potential to drive significant value across a number of therapeutic areas,” said Andrew Thompson, chief executive officer of Proteus Biomedical. “We have established a strong foundation with our strategic partners, and look to the next phase of expansion into new areas as the first Proteus-enabled products are commercialized.”
About Proteus Biomedical
Proteus Biomedical is pioneering intelligent medicine, an emerging field of advanced therapeutics that integrates in-body computer, sensor and communications technologies into existing medical device and pharmaceutical products. Proteus’s proprietary computing and sensing technologies enable proven therapies to be personalized, offering broad potential benefits across a range of care settings and therapeutic areas including cardiovascular, psychiatric, metabolic and neurologic disorders. The company’s first products, novel pacing and sensor-enabled devices for Cardiac Resynchronization Therapy, are in development in collaboration with world leaders in cardiovascular implantable devices.
Leave a reply
Latest Headlines:
Friday August 31, 2012
Zscaler Secures $38 Million Investment Round
Wednesday November 30, 2011
Health Care Solutions companies Infinity Pharmaceutics, NanoVobronix and Selventa raise funds.
Monday November 21, 2011
Panda Power opens $420 Million Fund for Solar and Natural Gas Projects
Thursday November 17, 2011
Better Place raises $200 Million for Electric Cars in the Series C of Funding
Wednesday November 16, 2011
Accel Partners raise $100 Million Big Data Fund to Invest in Hadoop, NoSQL and other Companies
Tuesday November 15, 2011
Skimlinks raises $4.5 Million to help Bloggers Increase their Gains
Monday November 14, 2011
Standing Cloud raises $3 Million to help New Cloud Providers grow Faster
Thursday November 10, 2011
Zillow acquires Diverse Solutions for $7.8 to help Real Estate Agents increase their Visibility